Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism

Overview of attention for article published in Thrombosis Journal, February 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 17,716 followers.

Comparison of the efficacy and safety of #rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patien… https://t.co/fH6rL2o3Lk

09 Feb 2023

Reply Repost Favourite

RT @Thrombosis_J: #OpenAccess #Thrombosis #Rivaroxaban might be a promising alternative to low-molecular-weight heparin as initial treatm…

07 Feb 2023

Reply Repost Favourite

Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism https://t.co/oYp2zbj83P

03 Feb 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.